Immune checkpoint inhibitors for treatment of small-cell lung cancer: a systematic review and meta-analysis

BACKGROUND: Small cell lung cancer (SCLC) is a very aggressive and proliferative disease, with little progress being having made for its treatment in decades. Our goal was to evaluate the effect of immune checkpoint inhibitors (ICIs) and identify optimal first-line interventions for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Zhicheng, Guo, Shenghu, Cao, Jing, Zhang, Yuehua, Guo, Xiaojin, Grossi, Francesco, Ichiki, Yoshinobu, Li, You, Wang, Zhiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106042/
https://www.ncbi.nlm.nih.gov/pubmed/33987403
http://dx.doi.org/10.21037/atm-21-1423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106042/
https://www.ncbi.nlm.nih.gov/pubmed/33987403
http://dx.doi.org/10.21037/atm-21-1423

Ejemplares similares